Burden of acromegaly in the United States: increased health services utilization, location of care, and costs of care Apr 5, 2021
The implications of suboptimal year-1 outcomes with disease-modifying therapy in employees with multiple sclerosis Apr 5, 2021
Biosimilars in the USA: Will New Efforts to Spur Approvals and Access Spur Uptake and Cost Savings? Jul 7, 2020
